Category: NARCO

NARCO: Revised Releases

The NARCO Trust has revised its releases to include a certification regarding the payment and/or resolution of certain Medicare related obligations. These revisions are made in accordance with the Amended Buyout Agreement approved by the United States Bankruptcy Court for the Western District of Pennsylvania on December 8, 2022. Please see the NARCO Trust’s Documents Page for the revised releases. The revised releases apply to all releases received after January 30, 2023.

All: Announcement – CRMC

CRMC will be implementing 2 Factor Authentication shortly. This adds an additional layer of security to all user accounts and thereby additional protections for each user of eClaims. This new feature, requires authentication beyond your username and password. The first time you log- in after implementation, the system will step you through the authentication process. Should you have questions/issues please email inquiry@claimsres.com.

NARCO: NARCO Asbestos Trust Notice of Holders of Annual Contribution Claims Timing of Payments

The NARCO Asbestos Trust (the “Trust”) will pay holders of Annual Contribution Claims on a monthly basis starting in August 2021 as a result of the Trust’s receipt of dividends paid on the Trust’s holdings of 79% of the stock of Harbison Walker International (“HWI”) and from investments of the dividends.

When the Trust exhausts those funds, the Trust will pay holders of Annual Contribution Claims based on the schedule and process in Section 2.3 (c) of the NARCO Asbestos Trust Agreement.

NARCO: COVID-19 Policy Update

SECOND NOTICE: 34 DAYS UNTIL EXPIRATION
  
IMPORTANT NOTICE
Expiration of Temporary COVID-19 Policy
NARCO Asbestos Trust
PLEASE READ CAREFULLY

Effective August 31, 2021, extension of the statute of limitations and deferral periods under the Temporary COVID-19 Policy will end. The full notice can be reviewed at: https://www.claimsres.com/wp-content/uploads/NARCO-June-Notice-re-COVID-19-Final-for-Implementation.pdf

NOTHING IN THIS COMMUNICATION IS LEGAL ADVICE OR MAY BE CONSTRUED AS LEGAL ADVICE. EACH CLAIMANT OR CLAIMANT’S COUNSEL IS RESPONSIBLE FOR DETERMINING WHAT IT MUST DO TO COMPLY WITH THE NARCO TRUST’S FILING REQUIREMENTS.

As the expiration of the COVID extension approaches, please note the Trust’s submission and documentation requirements to toll the running of the applicable statute of limitations for a claim based on a filing with the NARCO Asbestos Trust.  These requirements can be found in paragraph 1 of page 2 of the Supplemental Notice of NARCO Asbestos Trust Filing Deadlines – 11/7/16 document (http://www.claimsres.com/wp-content/uploads/2016/09/Notice-re-NARCO-Filing-Deadline-Requirements.pdf).

If you are uncertain whether a given claim has provided sufficient documentation and/or Proof of Claim Form information to toll the running of the applicable statute of limitations for a claim based on the filing with the Trust, you can confirm using the Claimant Locator feature in eClaims. The search results page contains a column “SOL Tolling Dt”. If no date appears under that column heading, the claim has not yet provided all the required information.

If you have additional questions, you may contact CRMC     through the message board, by email at NARCOInquiry@claimsres.com, or by telephone at 1-800-536-2722 or 703-204-9300.

Additional information regarding claims filing procedures and statute of limitations can be found on the Trust’s website.

NARCO: COVID-19 Policy Update

NOTICE FROM THE NARCO ASBESTOS TRUST
June 16, 2021

The NARCO Asbestos Trust adopts the following Notice effective July 1, 2021 (which replaces and supersedes the Trust’s Notice dated April 21, 2021):

In the March 23, 2020 Notice, the Trust tolled the statute of limitations and deferral periods for 90 days. In the June 24, 2020 Notice, the Trust resumed the running of the statute of limitations and deferral periods, but extended those deadlines through August 17, 2020, and further by subsequent Notices through June 30, 2021. Please take notice that, effective August 31, 2021, extension of the statute of limitations and deferral periods will end. For the avoidance of doubt, claims that became untimely during the extension periods (with consideration of the 90-day tolling period, if applicable) will be barred if not filed by August 31, 2021 at 11:59pm EDT. Also, claims that exhausted the permitted three-year deferral time during the extension periods (with consideration of the 90-day tolling period, if applicable) will be deemed to have been withdrawn per Section 5.3 of the TDP on August 31, 2021.           

    NOTE: THE TRUST WILL GRANT NO FURTHER EXTENSIONS OF THE AUGUST 31, 2021 DEADLINE. IF YOU HAVE A CLAIM IMPLICATED BY THIS NOTICE, YOU MUST FILE THAT CLAIM (FOR STATUTE OF LIMITATIONS PURPOSES) OR DEAL WITH THAT CLAIM (FOR DEFERRAL PURPOSES) BY NO LATER THAN AUGUST 31, 2021 AT 11:59PM EDT.

Effective July 1, 2021, the Trust will end its temporary suspension of any requirement that certain documents submitted to the Trust be notarized. The Trust notes that a statement under penalty of perjury consistent with applicable state or federal law (whether styled as a non-notarized affidavit, sworn statement, declaration, or statement under penalty of perjury) will continue to be permitted wherever a sworn affidavit is permissible or required. For more information, see the NARCO Asbestos Trust Website for Frequently Asked Questions – “Claim Filing and Review – What is required for a document, such as an affidavit, declaration, deposition, or interrogatory, to be acceptable for consideration in support of NARCO exposure?”

Effective July 1, 2021, the Trust will end the temporary suspension of any requirement that a document be witnessed by more than one person or by a person unrelated to the signatory set forth in the Trust’s various Notices. For the avoidance of doubt, the Trust does not require and has not required that documents be witnessed by more than one person or by a person unrelated to the signatory.

Effective July 1, 2021, the Trust will accept documents signed via DocuSign or another commercially reasonable e-signature program provided the claimant’s law firm has entered an electronic filer agreement with CRMC.